TRVI
Trevi Therapeutics Inc
14.50$
-5.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 99.7% | 91.7% | 99.3% | 98.2% | 98.7% | 99.7% | 97.9% | 98.7% | 99.1% | |
| 98.5% | 99.1% | 83.8% | 95.5% | 95.5% | 95.7% | 10.2% | 36.2% | 30.7% | 9.8% | |
| 98.5% | 99.1% | 83.8% | 95.5% | 95.5% | 95.7% | 98.0% | 92.8% | 97.0% | 97.3% | |
| 0.2% | 0.3% | 0.9% | 0.9% | 0.6% | 0.6% | – | – | 0.5% | 0.5% | |
| 0.0% | 0.3% | 6.8% | 2.7% | 1.9% | -0.6% | – | – | – | – | |
| 0.1% | 0.1% | 0.7% | 0.7% | 0.7% | 0.5% | 0.1% | – | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 307.0% | 33.5% | 15.5% | 9.1% | 42.1% | 55.6% | 12.6% | 7.7% | 10.1% | 5.3% | |
| 242.5% | 32.1% | 13.1% | 8.7% | 11.8% | 33.1% | 10.9% | 6.5% | 9.5% | 5.0% | |
| 202.1% | 23.8% | 0.0% | 0.2% | 0.2% | 15.5% | 5.7% | 0.3% | 0.3% | 0.2% | |
| 5.3% | 2.4% | 2.9% | 2.7% | 4.3% | 7.4% | 2.3% | 2.0% | 3.1% | 2.0% | |
| 60.9% | 0.0% | 5.3% | – | 29.6% | 22.5% | 1.7% | – | – | – | |
| -207.0% | 66.5% | 84.5% | 90.9% | 57.9% | 44.4% | 87.4% | 92.3% | 89.9% | 94.7% | |
| -858.1% | -379.8% | -534.4% | -190.4% | -311.8% | -470.2% | -170.8% | -267.5% | -258.8% | -170.5% | |
| 191.9% | 40.3% | 43.8% | 29.7% | 38.3% | 59.4% | 52.5% | 110.8% | 91.1% | 75.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.